Skip to main content

Table 4 Comparison of unrealistic and realistic RP patients’ characteristics

From: Markers of disease severity and positive family history are associated to significant risk perception in rheumatoid arthritis, while compliance with therapy is not: a cross-sectional study in 415 Mexican outpatients

Characteristics Unrealistic patients, N = 56 Realistic patients, N = 359 p
Socio-demographic
 Female sex1 55 (98.2) 332 (92.5) 0.152
 Years of age 58.5 (46.4–63) 54.7 (44.8–60.7) 0.082
 Years of formal education 9 (6–14.8) 9 (6–13) 0.372
 Medium-low SE level1 53 (94.6) 335 (93.3) 1
RA-related
 Serum positive RF1 48 (85.7) 325 (90.5) 0.337
 Serum positive ACCP1 49 (87.5) 324 (90.3) 0.481
 Years of disease duration 14 (8.3–20.3) 13.2 (7.7–18.3) 0.224
 Rheumatoid nodes1 28 (50) 67 (18.7) ≤ 0.0001
 RAPID-3 10.8 (2–18) 4.2 (1.6–10) 0.004
 High disease activity category1 25 (44.6) 71 (19.8) ≤ 0.0001
Patient-reported outcomes
 Pain-VAS 9.8 (5–31) 5 (2–16) ≤ 0.0001
 Overall disease-VAS 10 (5–35) 5 (1–18) 0.001
 HAQ score 1 (0–2.1) 0.25 (0–1.1) 0.001
 SF-36 score 61.3 (41.1–81.1) 73 (54.3–87) 0.002
 Mental component score (SF-36) 62.5 (42.9–86.9) 76.6 (56.9–88.4) 0.008
 Physical component score (SF-36) 55.3 (38–80) 70.4 (51.4–87.8) 0.003
Comorbidity
 Presence of comorbidity1 38 (67.9) 217 (60.4) 0.306
 Surgical joint replacement1 22 (39.3) 65 (18.1) 0.001
Treatment
 DMARDs/patient 1 (1–2) 1 (1–2) 0.031
 Corticosteroids use1 29 (51.8) 153 (42.6) 0.247
 Intensive treatment1 28 (50) 144 (40.1) 0.190
Compliance with treatment
 Adherence1 29 (51.8) 199 (55.4) 0.666
 Persistence1 30 (53.6) 197 (54.9) 0.886
 Concordance1 25 (44.6) 158 (44) 1
Miscellaneous
 Health Literacy1 46 (82.1) 283 (78.8) 0.723
 Adequate RA knowledge1 (based on CQ) 25 (44.6) 170 (47.4) 0.774
 RA family history1 28 (50) 158 (44) 0.470
Significant RP1 32 (57.1) 62 (17.3) ≤ 0.0001
Unfavorable medical criteria 6 (5–7) 5 (4–6) ≤ 0.0001
  1. Data are presented as the median and IQR unless otherwise indicated
  2. 1Number (%) of patients
  3. SE socioeconomic, RF rheumatoid factor, ACCP antibodies to cyclic citrullinated peptides, RAPID-3 Routine Assessment of Patients Index Score-3, VAS visual analogue scale, HAQ Health Assessment Questionnaire, SF-36 Short Form-36, DMARDs disease-modifying anti-rheumatic drugs, CQ Compliance Questionnaire, RA rheumatoid arthritis, RP risk perception